Wednesday, November 23, 2011

Disabled insured for good health In India

Disabled insured for good health
By Amitava Banerjee
The government-funded Niramaya scheme extends health insurance cover of Rs 100,000 to persons with autism, cerebral palsy, mental retardation and multiple disabilities, bringing a large section of disabled people into the healthcare system
About 15 years ago, Simita, then a 10-year-old student of the Indian Institute of Cerebral Palsy (IICP), Kolkata, was diagnosed with perforations in the heart after suffering from cough and breathing trouble for a long time. The doctor advised an operation that would cost Rs 1.25 lakh.
It was impossible for Simita’s parents to come up with the money. People with disability are not covered by health insurance. Members of the parent support group for disabled children at IICP met the insurance companies; nothing came of it. Finally, they raised the money through donations and Simita was operated upon successfully.
According to the 2001 census, about 22 million people in India are disabled. The WHO reports a figure of 70 million in 2007, the largest national population of disabled people in the world. Every year thousands of people with disabilities need medical care but cannot afford it because of the high cost of treatment. Following the National Trust for Welfare of Persons with Autism, Cerebral Palsy, Mental Retardation and Multiple Disabilities Act in 2000, under which children with mental disabilities were provided a legal guardian, the government has been under pressure from various organisations to allow people with these disabilities to be covered under life and health insurance schemes.
In 2008, the Government of India finally launched a health insurance scheme called Niramaya, for persons with autism, cerebral palsy, mental retardation and multiple disabilities. The scheme can serve a large section of people who so far have remained outside the scope of any medical insurance in the country.
The Niramaya scheme is disabled-friendly in form and conditions. It is implemented and monitored by the National Trust for Autism, Cerebral Palsy, Mental Retardation and Multiple Disabilities through a Third Party Nodal Agency (TPNA) with the active participation of the Local Level Committees (LLC). The TPNA will liaise with the insurance company, empanelled health service providers, LLCs, the National Trust, the state government and all the stakeholders concerned, to generate awareness about the scheme, to underwrite the risks, and to ensure speedy settlement of claims.
"The main idea in introducing such a scheme is to enable persons with disability to have access to health services like any other person," says Minakshi, an activist and head of the legal cell of Vidyasagar, an institution for children with cerebral palsy in Chennai. The services covered by the insurance scheme include regular medical check-ups, hospitalisation, therapy, corrective surgery and transportation. Being an affected person herself, Minakshi hopes that “with the availability of such health services at affordable costs, parents will be encouraged to take their children to health centres regularly, even for cases that are not serious. It will certainly improve the general health conditions of people with disability."
The annual premium for this health scheme is initially pegged at Rs 250. If an insured person with cerebral palsy, mental retardation, autism or multiple disabilities has an income of less than Rs 15,000 per month, the premium will be shared by the state government and the central government/National Trust.
The insurance cover for every person in the scheme is up to Rs 100,000. Since this is like a group insurance scheme, the insurance company has the right to stop entertaining any further claim any time in a year if the total amount of the claim exceeds the total premium amount. It is clearly mentioned in the brochure that "in case of total claims exceeding the total premium amount, the insurance company will cover the risk up to 120% of the total premium amount, ie, the insurance company can have a stop loss at 120% of total premium amount". Clients must therefore be made aware of their responsibility in incurring expenditure up to the level 'essential' so that more people can get the benefit.
The scheme aims to serve 100,000 people below the poverty line, with categorised disability in its first phase of implementation (two years) in 10 districts in 10 states: Central Delhi in Delhi, Chandigarh in Haryana, Jabalpur in Madhya Pradesh, Kaimur in Bihar, Agartala in the northeast, Rae Bareily in UP, Erode in Tamil Nadu, Ernakulam in Kerala, Ahmedabad in Gujarat and Bhageshwar in Uttarakhand.
The scheme is unique in the sense that there is no lower or upper age limit and a single premium applies across all age bands. Moreover, people may enter the scheme irrespective of the condition of their health. No medical tests are required prior to the contract with the insurance company, as is required for regular health insurance schemes. Pre- and post- hospitalisation expenses such as pathology, radiology, advanced diagnostic tests, post-operative monitoring and therapies etc are also included. All modes of authorised treatment – allopathic, homoeopathy, unani, ayurvedic, siddha etc -- are permitted. The scheme provides for cashless settlements in all listed hospitals and their branches all over India using smart or biometric cards provided by the authority. Treatment can also be availed of in hospitals other than those prescribed, but here payment is not cashless but will be reimbursed. Criteria for empanelled hospitals and nursing homes are also clarified. The National Trust will maintain the details of each beneficiary covered under the scheme, including their identification.
“The programme is bound to change the lives of people with disability, especially the poor section and those identified as living below the poverty line (BPL). These people remain outside the ambit of even minimal social protection. Access to healthcare facilities will surely boost their morale,” says Sujata Parekh, social activist and consultant at the IICP. She points out that the scheme is a realisation of the commitment made by the government in various legislations like the Persons with Disability Act, 1995, and the National Trust Act, 2000. It also fulfils the commitment made to the United Nations by ratifying the UN Convention on the Rights of Disabled People in 2007.
Benefits assured to people with disability under various legislations have not often materialised. For example, people with disability are supposed to get a disability identity card issued by the state authority on the basis of the medical certificate that they produce. This card allows them to avail of various government facilities such as concessions in various modes of transport, enrolment in employment exchanges, stipend, pension etc. However, lack of coordination between medical professionals and the executive authority has resulted in a majority of disabled people in the country not having this card and therefore being deprived of the facilities that are rightfully theirs.
In the last decade, the Life Insurance Corporation tabled a life insurance plan for people with disability. Under the plan, the affected person would receive money in the form of a monthly pension from the insured sum only after the death of the parents. Parents, however, were in favour of getting the money in a lumpsum after the tenure of the premium payment so that they could plan for their children’s future. At that time, children with delayed mental age could not legally handle money or property even after attaining adulthood, and the provision for appointing a legal guardian for adult persons who were incapable of taking care of themselves came into effect along with the National Trust Act, in 2000.
The Niramaya scheme can be misused like any other health insurance scheme. “Medical insurance is a scientific system to meet the urgent needs of society. Healthcare schemes in India, however, are mostly designed by agents, hospitals, nursing homes and doctors. Very often costs are manipulated and inflated – in medical tests, prescribed medicines and stay in hospitals," said Kusal Nag, an official of a nationalised insurance company. Like some other insurance companies, the Niramaya scheme has not defined the limitation of bed charges during hospitalisation so as to avoid misuse of social funds. It is important to curb the tendency to abuse this welfare scheme so that a larger number of needy people can take advantage of it.
Sarada Ambal, mother of an adult son with delayed mental development, suggests that the smart card can be put to a number of uses. “The smart health card or biometric card with the health insurance scheme will be more beneficial if the card could also be used as a permanent identity card for people with permanent disability even if the person discontinues the scheme,” she says.
How to avail of the scheme
Contact the disability cell of your state social welfare ministry/related institutions/the National Trust/related NGOs. NGOs should send the enrolment form/applications under Niramaya directly to the National Trust either by post or electronically through their MIS. For electronic mode, an incentive of Rs 5 per form shall be given to NGOs in addition to Rs 15 for new enrolment. Forms are also available from 16B, Bada Bazar Road, Old Rajinder Nagar, New Delhi - 110060 Phone 011- 431- 87878 or can be downloaded from the National Trust website http://www.thenationaltrust.org.in/

Thursday, November 17, 2011

Smart Nutrition presents Cranberry Plus for UTI- a prevalent disease in India among Woman

Smart Nutrition, the leading Vitamins, health supplements, sports nutrition and Fitness products suppliers across U.K., U.S., Canada, Australia and now India, presents Cranberry Plus for Urinary Tract Infection.
New Delhi, Delhi, April 18, 2011 /India PRwire/ -- Smart Nutrition, the leading Vitamins, health supplements, sports nutrition and Fitness products suppliers across U.K., U.S., Canada, Australia and now India, presents Cranberry Plus for Urinary Tract Infection.
Cranberry Plus helps maintaining a healthy urinary tract by inhibiting the adhesion of e. coli bacteria to the lining of the bladder. Cranberry also provides vitamin C, a powerful antioxidant that is beneficial to the immune system.
Why Cranberry?
Modern research has suggested that cranberry may prevent urinary tract infections because it prevents E. coli, the bacterium that causes most urinary tract infections, from attaching to the walls of the bladder. In a double-blind trial, elderly women who drank 10 ounces (300 ml) of cranberry juice per day had a decrease in the amount of bacteria in their urine. In another study, elderly residents of a nursing home consumed either four ounces (120 ml) of cranberry juice or six capsules containing concentrated cranberry daily for 13 months. During that time, the number of UTIs decreased by 25%. A small preliminary trial found that supplementation with encapsulated cranberry concentrate (400 mg twice per day for three months) significantly reduced the recurrence of UTIs in women (aged 18-45) with a history of recurrent infections.
Cranberry juice has also been found to be as effective as the antibiotic cefaclor for preventing UTIs in children who had recurrent UTIs because of a condition that causes urine to flow backwards from the bladder into the ureters (vesicoureteral reflux). In that study, the children received a cranberry juice concentrate that was equivalent to 200 ml of cranberry juice per day.
Cranberry Plus is available for Rs. 2793 for 180 tablets and Cranberry 100 tablets for Rs. 669. These tablets are available at Religare Wellness, Planet Sports, Decathlon, and Gyms and Fitness Centers across India.
Notes to Editor
About Smart Nutrition
Smart Nutrition is a pioneer in providing health supplements and Fitness products, across Europe and Asia. Their prime focus is to provide best products for Wellness, Skin Care, Body Care, Hair Care, Teen's Care and Men's Care.
After conducting précised scientific researches, they have come up with a wide range of products in Multivitamins, Dietary supplements, Sport nutrition's, Joint solutions ,Omega 3-6-9 and many more products
Smart nutrition creates an experience which follows a scientific approach to achieve balance in human physiology by energizing the body's inner intelligence.
They are on a mission to provide the Indian market with the latest safe, reliable, effective, trusted, Quality, Health, Nutritional, Sports and Fitness products from around the world and for that is already retailing from outlets including Religare Wellness, Planet Sports, Decathlon, and Gyms and Fitness Centers across India.

Tuesday, November 15, 2011

The world's first official trial using human embryonic stem cells in patients has been halted. Geron, based in California, made the sudden announcement that it was halting further work in this field

.In a statement the company said in the "current environment of capital scarcity and uncertain economic conditions" it had decided to concentrate instead on developing cancer treatments. Geron said it was seeking partners to enable further development of its stem cell programmes. The press statement implies the decision is purely a financial one - by stopping its stem cell programme it will cut its workforce by more than a third and save millions of dollars.
But the company has already invested tens of millions in the stem cell therapy over the past decade. Its submission to the US Food and Drug Administration to conduct the first trial in patients of human embryonic stem cells was the largest and most complex ever submitted.
Geron had injected stem cells into the spine of a small number of spinal patients to test safety. In its statement the company said the treatment had been "well tolerated with no serious adverse events".
The decision does seem to be extraordinary given the huge investment of time and resources. When I visited Geron nearly three years ago, the then chief executive Dr Tom Okarma claimed the technology had an incredible future (Green light for US stem cell work):
"What stem cells promise for a heart attack or spinal cord injury or diabetes is that you go to the hospital, you receive these cells and you go home with a repaired organ, that has been repaired by new heart cells or new new nerve cells or new islet cells that have been made from embryonic stem cells."
If that future exists, it won't be Geron that will now lead the way.
Ben Sykes, Executive Director of the UK National Stem Cell Network, said:
"Stem cell research continues to show great promise in helping many people currently suffering from incurable conditions and injuries. It is disappointing that Geron has taken the decision to stop its spinal cord injury trial but we hope that the company is able to find new partners who can take on the work and provide the necessary finance."
Joanna Knott, Co-Founder and Chair of SpinalCure Australia said: "This is incredibly sad and frustrating news for people with spinal injuries and their families. It is devastating for those people who will have a spinal injury and may as a result of this research been cured.
Daniel Heumann, who is on the board of the Christopher and Dana Reeve Foundation, was more forthright in The Washington Post online which reported him as saying: "I'm disgusted. It makes me sick. To get people's hopes up and then do this for financial reasons is despicable. They're treating us like lab rats."
John Martin, Professor of Cardiovascular Medicine at University College London said: "The Geron trial had no real chance of success because of the design and the disease targeted. It was an intrinsically flawed study. And for that reasons we should not be describing this as a set back.
"The first trials of stem cell that will give an answer are our own in the heart. The heart is an organ that can give quantitative data of quality."
Josephine Quintavalle from the group Comment on Reproductive Ethics said: "At long last after 10 years of unremitting hype, reality has caught up with embryonic stem cell claims. If Geron is abandoning this project it is because it is simply not working, despite the millions of dollars and hot air that has been invested in the promotion of this research."